- Home
- IKT vs GNSS Comparison
IKT vs GNSS Comparison
Compare IKT & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- GNSS
- Stock Information
- Founded
- IKT 2008
- GNSS 1992
- Country
- IKT United States
- GNSS United States
- Employees
- IKT N/A
- GNSS N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- GNSS Consumer Electronics/Appliances
- Sector
- IKT Health Care
- GNSS Consumer Staples
- Exchange
- IKT Nasdaq
- GNSS Nasdaq
- Market Cap
- IKT 159.2M
- GNSS 135.2M
- IPO Year
- IKT 2020
- GNSS N/A
- Fundamental
- Price
- IKT $2.27
- GNSS $3.05
- Analyst Decision
- IKT Strong Buy
- GNSS Strong Buy
- Analyst Count
- IKT 2
- GNSS 3
- Target Price
- IKT $6.50
- GNSS $5.33
- AVG Volume (30 Days)
- IKT 194.9K
- GNSS 138.6K
- Earning Date
- IKT 03-26-2025
- GNSS 02-11-2025
- Dividend Yield
- IKT N/A
- GNSS N/A
- EPS Growth
- IKT N/A
- GNSS N/A
- EPS
- IKT N/A
- GNSS N/A
- Revenue
- IKT $1.00
- GNSS $24,008,000.00
- Revenue This Year
- IKT N/A
- GNSS $136.42
- Revenue Next Year
- IKT N/A
- GNSS $56.53
- P/E Ratio
- IKT N/A
- GNSS N/A
- Revenue Growth
- IKT N/A
- GNSS N/A
- 52 Week Low
- IKT $1.12
- GNSS $1.54
- 52 Week High
- IKT $4.20
- GNSS $4.04
- Technical
- Relative Strength Index (RSI)
- IKT 38.70
- GNSS 54.45
- Support Level
- IKT $1.90
- GNSS $2.97
- Resistance Level
- IKT $2.37
- GNSS $3.20
- Average True Range (ATR)
- IKT 0.25
- GNSS 0.14
- MACD
- IKT -0.07
- GNSS 0.03
- Stochastic Oscillator
- IKT 34.91
- GNSS 72.73
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.